Therefore, we assessed the effects of these compounds in immunodeficient subcutaneous KPARG12C tumour-bearing Rag1−/− mice which lack functional T and B lymphocytes and are incapable of inducing adaptive immune responses. The gene discussed is RAG1; the disease is neoplasm.